PT - JOURNAL ARTICLE AU - Ora Israel AU - Maya Mor AU - Luda Guralnik AU - Nirit Hermoni AU - Diana Gaitini AU - Rachel Bar-Shalom AU - Zohar Keidar AU - Ron Epelbaum TI - Is <sup>18</sup>F-FDG PET/CT Useful for Imaging and Management of Patients with Suspected Occult Recurrence of Cancer? DP - 2004 Dec 01 TA - Journal of Nuclear Medicine PG - 2045--2051 VI - 45 IP - 12 4099 - http://jnm.snmjournals.org/content/45/12/2045.short 4100 - http://jnm.snmjournals.org/content/45/12/2045.full SO - J Nucl Med2004 Dec 01; 45 AB - Rising serum tumor markers may be associated with negative imaging in the presence of cancer. CT and 18F-FDG PET may yield incongruent results in the assessment of tumor recurrence. The present study evaluates the incremental role of 18F-FDG PET/CT for the diagnosis and management of cancer patients with increasing levels of tumor markers as the sole indicator of potential recurrence after initial successful treatment. Methods: Thirty-six cancer patients with increasing levels of tumor markers during follow-up and negative CT underwent 18F-FDG PET/CT, which showed 111 sites of increased tracer uptake. PET/CT was compared with PET results on a site-based analysis for characterization of 18F-FDG foci and on a patient-based analysis for diagnosis of recurrence. The clinical impact of PET/CT on further patient management was evaluated. Results: Thirty patients (83%) had recurrence in 85 malignant sites (77%). For the site-based analysis, PET had a sensitivity, specificity, accuracy, positive predictive value, and negative predictive value of 96%, 50%, 85%, 85%, and 82%, respectively, as compared with the performance indices of PET/CT of 100%, 89%, 97%, 97%, and 100%, respectively. There was a statistically significant difference between the specificity (P &lt; 0.05) and accuracy (P &lt; 0.001) of PET and PET/CT for precise characterization of suspected lesions. For the patient-based analysis, PET had a sensitivity, specificity, and accuracy of 93%, 50%, and 86%, respectively, as compared with PET/CT with values of 93%, 67%, and 89%, respectively (P = not significant). PET/CT was the single modality that directed further management and treatment planning in 12 patients (33%). Conclusion: The results of this study indicate that PET/CT may improve the accuracy of occult cancer detection and further lead to management changes in patients with increasing levels of tumor markers as the sole suspicion of recurrent malignancy.